MedTrace Logo

Medium Chain Triglycerides and Brain Metabolism in Alzheimer's Disease

NCT02709356 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-10-10

No results posted yet for this study

Summary

Evaluate and compare the changes in brain ketone and glucose uptake after taking two different MCT oil emulsions (60-40 oil or C8 oil) for one month, in a group of people with Alzheimer's disease and a control group.

Conditions

Interventions

DIETARY_SUPPLEMENT

1-month of 60-40 MCT oil

1-month supplementation of 30 g MCT oil (60% C10 + 40% C8)/day

DIETARY_SUPPLEMENT

1-month of C8 MCT oil

1-month supplementation of 30 g MCT oil (100% C8)/day (1-month of C8 MCT oïl)

Sponsors & Collaborators

  • Fondation Vitae

    collaborator OTHER

  • Université de Sherbrooke

    lead OTHER

Principal Investigators

  • Stephen Cunnane, PhD · Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS) - Université de Sherbrooke

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02709356 on ClinicalTrials.gov